Literature DB >> 165764

Thymosin-induced differentiation of murine thymocytes in allogeneic mixed lymphocyte cultures.

G H Cohen, J A Hopper, A L Goldstein.   

Abstract

Calf thymosin is shown to enhance the one-way MLR of CBA thymocytes cultured with allogeneic mitomycin-C- treated C57BL/J6 spleen cells. Thymosin does not enhance the one-way MLR of CBA thymocytes cultured with syngeneic mitomucin-C-treated spleen cells. Based on this finding we present a relatively simple, rapid and quantitative in vitro microculture hioassay for inducers of T-cell differentiation and propose that thymosin treatment, when accompanied by antigen presentation, induces the two-step maturational sequence of pre-T yields T1 yields T2.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165764     DOI: 10.1111/j.1749-6632.1975.tb29064.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Amplification of the proliferative response to alloantigen by a factor present in an extract of syngeneic thymic lymphoid cells.

Authors:  P W Wright; S M Loop
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Immunomodulation and therapeutic characterization of thymosin fraction five.

Authors:  J E Talmadge; K A Uithoven; B F Lenz; M Chirigos
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  The serum thymic factor (FTS). Chemical and biological aspects.

Authors:  J M Pleau; M Dardenne; J F Bach
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

4.  Receptors for thymosin fraction V on rat thymic lymphocytes.

Authors:  R Brelinska; J B Warchoł
Journal:  Experientia       Date:  1982-05-15

5.  Induction of a T-cell specific antigen on bone marrow lymphocytes with thymus RNA.

Authors:  S J Archer
Journal:  Immunology       Date:  1978-01       Impact factor: 7.397

6.  Prolongation of murine skin grafts by FTS and its synthetic analogues.

Authors:  D Kaiserlian; A Dujic; M Dardenne; J F Bach; D Blanot; E Bricas
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.